JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.68% |
| 2 | Financials | 11.13% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Healthcare | 9.62% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAO
3301
Youdao
DAO
$2.16B
| $3.21M | ﹤0.01% |
138,783
+19,558
| +16% | +$473K |
|
|
PIPP
3302
DELISTED
Pine Island Acquisition Corp.
PIPP
| $3.2M | ﹤0.01% |
328,786
+8,532
| +3% | +$84.4K |
|
|
KBAL
3303
DELISTED
Kimball International
KBAL
| $3.2M | ﹤0.01% |
243,121
+23,137
| +11% | +$315K |
|
3304
Kodiak Sciences
KOD
$2.53B
| $3.19M | ﹤0.01% |
34,334
+2,733
| +9% | +$262K |
|
|
RFP
3305
DELISTED
Resolute Forest Products Inc.
RFP
| $3.19M | ﹤0.01% |
261,749
+214,569
| +455% | +$3.01M |
|
|
ONEM
3306
DELISTED
1Life Healthcare
ONEM
| $3.19M | ﹤0.01% |
96,541
-826,991
| -90% | -$31.2M |
|
3307
Patria Investments
PAX
$1.86B
| $3.18M | ﹤0.01% |
180,462
+170,170
| +1,653% | +$2.72M |
|
|
USDP
3308
DELISTED
USD PARTNERS LP
USDP
| $3.18M | ﹤0.01% |
420,903
-9,561
| -2% | -$60.2K |
|
3309
Bar Harbor Bankshares
BHB
$679M
| $3.18M | ﹤0.01% |
110,978
-31,081
| -22% | -$916K |
|
3310
Beazer Homes USA
BZH
$874M
| $3.18M | ﹤0.01% |
164,694
-76,153
| -32% | -$1.67M |
|
3311
ThredUp
TDUP
$410M
| $3.17M | ﹤0.01% |
109,006
-211,205
| -66% | -$4.55M |
|
|
HARP
3312
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.17M | ﹤0.01% |
22,832
-1,177
| -5% | -$225K |
|
|
FIRY
3313
Firy Inc
FIRY
$149M
| $3.15M | ﹤0.01% |
7,264
+6,239
| +609% | +$2.23M |
|
3314
Abeona Therapeutics
ABEO
$337M
| $3.15M | ﹤0.01% |
80,880
+4,338
| +6% | +$177K |
|
3315
Universal Corp
UVV
$1.12B
| $3.15M | ﹤0.01% |
55,270
-4,856
| -8% | -$280K |
|
3316
State Street SPDR S&P Transportation ETF
XTN
$398M
| $3.15M | ﹤0.01% |
37,067
+1,799
| +5% | +$160K |
|
3317
Shake Shack
SHAK
$3.03B
| $3.14M | ﹤0.01% |
29,340
-39,973
| -58% | -$4.03M |
|
3318
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $3.14M | ﹤0.01% |
118,685
-13,887
| -10% | -$369K |
|
3319
PUT
American Tower
AMT
$82B
| $3.13M | ﹤0.01% |
+11,600
| New | +$2.96M |
|
3320
CALL
Wolfspeed
WOLF
$1.64B
| $3.13M | ﹤0.01% |
32,000
+6,900
| +27% | +$696K |
|
|
PSTX
3321
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.13M | ﹤0.01% |
312,694
+1,832
| +0.6% | +$16.4K |
|
|
STR
3322
DELISTED
Sitio Royalties
STR
| $3.13M | ﹤0.01% |
153,843
-25,671
| -14% | -$493K |
|
3323
BioCryst Pharmaceuticals
BCRX
$2.44B
| $3.12M | ﹤0.01% |
197,486
+33,518
| +20% | +$455K |
|
3324
CALL
Certara
CERT
$1.23B
| $3.12M | ﹤0.01% |
+110,100
| New | +$3.06M |
|
|
BHVN
3325
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.12M | ﹤0.01% |
+32,100
| New | +$2.61M |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.